Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.

Journal of lipid research - 1 Sept 2006

Vaessen Stefan F C, Schaap Frank G, Kuivenhoven Jan-Albert, Groen Albert K, Hutten Barbara A, Boekholdt S Matthijs, Hattori Hiroaki, Sandhu Manjinder S, Bingham Sheila A, Luben Robert, Palmen Jutta A, Wareham Nicholas J, Humphries Steve E, Kastelein John J P, Talmud Philippa J, Khaw Kay-Tee

Abstract excerpt

In mouse models, apolipoprotein A-V (apoA-V) exhibits triglyceride (TG)-lowering effects. We investigated the apoA-V/TG relationship and the association of apoA-V with coronary artery disease (CAD) risk by determining serum apoA-V levels and genotypes in a nested case-control (n = 1,034/2,031) study. Both univariate and multivariate apoA-V levels showed no association with future CAD (P = 0.4 and 0.5,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-V
Share to Apolipoproteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins A

Share to Coronary Artery Disease

Share to Linkage Disequilibrium

Share to Multivariate Analysis

Share to Triglycerides

Share to United Kingdom

Source

Identifiers

PMID: 16769999
DOI: 10.1194/jlr.M600233-JLR200

Genes

CAD
LPL
APOC3

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.PMID 16769999Read ↗

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.Semantic proximity Read ↗

APOE genotype, lipids, and coronary heart disease risk: a prospective population study.Semantic proximity Read ↗

Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics.Semantic proximity Read ↗

Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.Semantic proximity Read ↗

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.Semantic proximity Read ↗

The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.Semantic proximity Read ↗

[Apolipoprotein AV and triglyceridemia].Semantic proximity Read ↗

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study.Semantic proximity Read ↗

Apolipoprotein E gene polymorphism effects triglycerides but not CAD risk in Caucasian women younger than 65 years.Semantic proximity Read ↗

APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.Semantic proximity Read ↗

Genetically determined absence of HDL-cholesterol and coronary atherosclerosis.Semantic proximity Read ↗

APOC3 mutation, serum triglyceride concentrations, and coronary heart disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.